Phenanthrene

Phenanthrene

SCHEMBL29358486

c1ccc2c(c1)ccc1ccccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 6/20 1.00
ALDH1A1 P00352 5/20 1.00
HSD17B10 Q99714 4/20 1.00
TSHR P16473 3/20 1.00
TDP1 Q9NUW8 1/20 1.00
HPRT1 P00492 3/20 0.86
HIF1A Q16665 1/20 0.75
CYP1B1 Q16678 1/20 0.75
PAX8 Q06710 1/20 0.63
CYP1A2 P05177 4/20 0.56
HPGD P15428 2/20 0.56
THRB P10828 1/20 0.56
PTPN22 Q9Y2R2 1/20 0.55
CYP3A4 P08684 2/20 0.55
ALOX12 P18054 1/20 0.54
KEAP1 Q14145 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenanthrene SCHEMBL7643 1.00 CYP2A6 (1.00) CYP2A6ALDH1A1HSD17B10TSHRTDP1
Phenanthrene SCHEMBL29477074 1.00 CYP2A6 (1.00) CYP2A6ALDH1A1HSD17B10TSHRTDP1
Phenanthrene SCHEMBL8873977 1.00 CYP2A6 (1.00) CYP2A6ALDH1A1HSD17B10TSHRTDP1
Phenanthrene SCHEMBL1330750 1.00 CYP2A6 (1.00) CYP2A6ALDH1A1HSD17B10TSHRTDP1
Phenanthrene SCHEMBL30932938 1.00 CYP2A6 (1.00) CYP2A6ALDH1A1HSD17B10TSHRTDP1
Phenanthrene SCHEMBL27458043 1.00 CYP2A6 (1.00) CYP2A6ALDH1A1HSD17B10TSHRTDP1
Phenanthrene SCHEMBL25318236 0.96 CYP2A6 (0.92) CYP2A6ALDH1A1HSD17B10TSHRTDP1
Phenanthrene SCHEMBL3859754 0.96 CYP2A6 (0.92) CYP2A6ALDH1A1HSD17B10TSHRTDP1
Phenanthrene SCHEMBL6281749 0.96 CYP2A6 (0.92) CYP2A6ALDH1A1HSD17B10TSHRTDP1
Phenanthrene SCHEMBL16742390 0.96 CYP2A6 (0.92) CYP2A6ALDH1A1HSD17B10TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 534 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4476181-B1 METHOD FOR PURIFYING RUTHENIUM FROM TECHNETIUM AND METAL IMPURITIES IN AQUEOUS NITRIC ACID SOLUTION COMMISSARIAT ENERGIE ATOMIQUE (FR) 2026-04-01 EP claimed
CN-119930586-A Organic electroluminescent material and device 环球展览公司 2025-05-06 CN claimed
CN-119060099-A Organic electroluminescent material and device 环球展览公司 2024-12-03 CN claimed
CN-118290920-B High-whiteness high-light-transmittance PCR (polymerase chain reaction) polymer composite material, preparation method and application thereof 广东特普爱高分子材料有限公司 2024-11-01 CN claimed
CN-113968873-B Organic electroluminescent material and device thereof 北京夏禾科技有限公司 2024-10-22 CN claimed
CN-113968875-B Electroluminescent material and device 北京夏禾科技有限公司 2024-10-22 CN claimed
CN-114163424-B Organic electroluminescent material and device thereof 北京夏禾科技有限公司 2024-10-18 CN claimed
CN-114591341-B Electroluminescent material and device thereof 北京夏禾科技有限公司 2024-10-15 CN claimed
CN-118619974-A Synthesis method of asymmetric 1, 10-phenanthroline compound for OLED (organic light emitting diode) material 大连理工大学 2024-09-10 CN claimed
CN-118307710-A Composition for contact lens and contact lens 视阳光学股份有限公司 2024-07-09 CN claimed
EP-3556753-B1 COMPOUND AND ORGANIC SEMICONDUCTING LAYER, ORGANIC ELECTRONIC DEVICE, DISPLAY DEVICE AND LIGHTING DEVICE COMPRISING THE SAME NOVALED GMBH (DE) 2023-10-11 EP claimed
CN-114316239-B Polycarbonate polyol with side chain containing phosphorus as well as preparation method and application thereof 万华化学集团股份有限公司 2023-08-11 CN claimed
WO-2023137534-A1 MODIFIED TRANSDUCER, TRANSDUCTION MECHANISM AND METHOD OF DETECTING AND/OR QUANTIFYING SPECIES OF ANALYTICAL INTEREST WITH A MODIFIED TRANSDUCER UNIVERSIDADE ESTADUAL PAULISTA JULIO DE MESQUITA FILHO (BR) 2023-07-27 WO claimed
CN-116462658-A Synthesis method and application of copper-catalyzed aryl sulfide salt and aryl silane cross-coupling reaction to construct novel C-C bond 中国科学院大学 2023-07-21 CN claimed
CN-113831442-B High-cost-performance flame-retardant polymethacrylimide foam and preparation method thereof 湖南兆恒材料科技有限公司 2023-07-07 CN claimed
US-11641774-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-05-02 US claimed
WO-2022214506-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-10-13 WO claimed
WO-2022214566-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-10-13 WO claimed
EP-4048675-A1 COMPOUNDS THAT CAN BE USED IN AN ORGANIC ELECTRONIC DEVICE Merck Patent GmbH (DE) 2022-08-31 EP claimed
US-20220223801-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-07-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220223801-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES TMEM109, PIEZO1, L1CAM CYP2A6 1090/4885ALDH1A1 8/4885HSD17B10 1776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.